Choline is a required nutrient with roles in liver and brain function, lipid metabolism, and fetal development. Recent data suggest that choline requirements may be altered by polymorphisms in the phosphatidylethanolamine N-methyltransferase (PEMT) gene (i.e., 5465G→A; rs7946 and -744G→C; rs12325817) and in the methylenetetrahydrofolate dehydrogenase (MTHFD1) gene (i.e., 1958G→A; rs2236225). This controlled feeding study, conducted in 2000-2001, examined the effects of the PEMT and MTHFD1 genetic variants on biomarkers of choline metabolism in premenopausal Mexican American women (n=43) after a 7-wk period of folate restriction (135μg as dietary folate equivalents, DFE) and after a 7-wk period of folate treatment (400 and 800μg DFE/d combined). Throughout the 14-wk study choline intake remained constant at 349mg/d. The genotype frequencies of the women were 3GG, 19GA, and 21AA for PEMT G5465A; 9GG, 17GC and 17CC for PEMT G-744C; and 9GG, 21GA and 13AA for MTHFD1 G1958A. During folate restriction, homocysteine was adversely influenced by PEMT 5465AA (P=0.001 relative to the G allele) and by MTHFD1 1958AA (P=0.085 relative to 1958GG); whereas the decline in phosphatidylcholine was attenuated by PEMT -744CC (P=0.017 relative to -744GG). During folate treatment, no effects of the genotypes on the response of the measured variables were detected. These data suggest that polymorphisms in genes relevant to choline metabolism modulate parameters of choline status when folate intake is restricted. Additional studies with larger samples sizes are needed to examine the relationship between these genetic variants and varied choline intake in populations with increased demands for choline (i.e., pregnant women).

We previously showed that provision of the folate recommended dietary allowance and either 300, 550, 1100, or 2200 mg/d choline for 12 wk resulted in diminished folate status and a tripling of plasma total homocysteine (tHcy) in men with the methylenetetrahydrofolate reductase (MTHFR) 677TT genotype. However, the substantial variation in tHcy within the 677TT genotype at wk 12 implied that several factors were interacting with this genotype to affect homocysteine. As an extension of this work, the present study sought to identify the main predictors of wk-12 plasma tHcy, alone and together with the MTHFR C677T genotype (29 TT, 31 CC), using linear regression analysis. A basic model explaining 82.5% of the variation (i.e. adjusted R(2) = 0.825) was constructed. However, the effects of the variables within this model were dependent upon the MTHFR C677T genotype (P for interaction < or = 0.021). Within the 677TT genotype, serum folate (P = 0.005) and plasma riboflavin (P = 0.002) were strong negative predictors (inversely related) explaining 12 and 15%, respectively, of the variation in tHcy, whereas choline intake (P = 0.003) and serum creatinine (P < 0.001) were strong positive predictors, explaining 19 and 25% of the variation. None of these variables, except creatinine (P = 0.021), correlated with tHcy within the 677CC genotype. Of the 8 additional polymorphisms tested, none appeared to influence tHcy. However, when creatinine was not in the model, the phosphatidylethanolamine N-methyltransferase 5465G-->A variant predicted lower tHcy (P < 0.001); an effect confined to the MTHFR 677TT genotype. Thus, in folate-deplete men, several factors with roles in 1-carbon metabolism interact with the MTHFR C677T genotype to affect plasma tHcy.

We previously showed that provision of the folate RDA and either 300, 550, 1100, or 2200mg choline/day resulted in diminished folate status and a tripling of plasma total homocysteine (tHcy) in men with the MTHFR 677TT genotype However, the substantial variation in tHcy within the 677TT genotype implied that several factors were interacting with this genotype to affect homocysteine. This study sought to identify the main predictors of wk‐12 plasma tHcy, alone and together with the MTHFR C677T genotype (29 TT, 31 CC), using linear regression analysis. A basic model explaining 82.5% of the variation (i.e., adjusted R2 =0.825) was constructed. Within the 677TT genotype, serum folate (P=0.005) and plasma riboflavin (P=0.002) were strong negative predictors (inversely related) explaining 12% and 15% of the variation in tHcy; whereas choline intake (P=0.003) and serum creatinine (P<0.001) were strong positive predictors explaining 19% and 25% of the variation. None of these variables, except creatinine (P=0.021), correlated with tHcy within the 677CC genotype. When creatinine was not in the model, the PEMT 5465G>A variant predicted lower tHcy (P<0.001); an effect confined to the MTHFR 677TT genotype. Thus, in folate deplete men, several factors with roles in one‐carbon metabolism interact with the MTHFR C677T genotype to affect plasma tHcy.